DABRAFENIB
UNII QGP4HA4G1B

Substance Identification & Data

This profile provides standardized clinical and technical data for Dabrafenib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QGP4HA4G1B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1195765-45-7 and the RxNorm Concept ID (RxCUI) 1424911. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QGP4HA4G1B

CAS Registry Number

1195765-45-7

RxNorm Concept ID

1424911

Detailed Substance Profile

Preferred Name

DABRAFENIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

QGP4HA4G1B

The specific atomic composition represented as a molecular structure string.

InChIKey

C23H20F3N5O2S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BFSMGDJOXZAERB-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C82386

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44462760

Unique identification number in the NCBI database of chemical substances.

INN ID

9458

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-156

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O=S(c1c(F)cccc1F)(=O)Nc2cccc(-c3c(-c4ccnc(N)n4)sc(C(C)(C)C)n3)c2F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dabrafenib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.